Wellbeing Digital Sciences Inc. (KONEF) Stock
With its origins as KetamineOne Capital Limited, this innovative wellness organization is dedicated to advancing ketamine-assisted therapy and psychedelic medicines. It achieves this mission by managing a network of healthcare clinics across North America.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Wellbeing Digital Sciences Inc.
With its origins as KetamineOne Capital Limited, this innovative wellness organization is dedicated to advancing ketamine-assisted therapy and psychedelic medicines. It achieves this mission by managing a network of healthcare clinics across North America. The company, which commenced operations in 2017 and is headquartered in Vancouver, Canada, was formerly recognized as Myconic Capital Corp. Its transition to the KetamineOne Capital Limited name occurred in June 2021.
Wellbeing Digital Sciences Inc. (KONEF) stock trades at $0.00 with a market capitalization of $1576. The stock is valued at price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, Wellbeing Digital Sciences Inc. generates a return on equity (ROE) of -656.27%, return on capital employed of -200.00%, an operating margin of -320.82%, a net profit margin of -416.67%.
Official website: www.ketamine.one